Clinical Trial Update: ONO-7436 Phase II Study in Japan [Phase 2]

View source ↗

Summary

Phase II study of ONO-7436 in Japan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• ONO-7436

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Malignant Tumor | Phase 2 | Status: COMPLETED